Medical Xpress·3 min read·hard
Inhibiting protein to treat myeloproliferative neoplasms shows preclinical promise
S
St. Jude Children's Research Hospital
✦AI Summary
Researchers at St. Jude Children's Research Hospital have discovered that inhibiting the menin protein shows promise in treating myeloproliferative neoplasms. Preclinical studies in mice demonstrated improved survival rates and normalized blood cell counts.
edited by Gaby Clark , reviewed by Andrew Zinin
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in